"Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy"

NCT02375217 Phase 4 COMPLETED

Prospective Randomized non inferiority Trial involving adult patients undergoing elective surgery under general anesthesia.56 Patients will be enrolled in 2 groups : full dose sugammadex vs half dose sugammadex for reversal of NMB.

Details

Lead sponsor	American University of Beirut Medical Center
Phase	Phase 4
Status	COMPLETED
Enrolment	56
Start date	2014-10
Completion	2015-10

Conditions

• Anesthesia Recovery

Interventions

• Sugammadex
• Sugammadex
• Neostigmine
• glycopyrrolate

Primary outcomes

• TOF ratio of 0.9 — within 5 minutes

Countries

Lebanon